We were delighted to hear that Forum Partner Peter Vogel has been appointed as the holder of the new Debiopharm Chair for Family Philanthropy at the IMD business school, created thanks to a donation of several million Swiss francs by the biopharmaceutical company Debiopharm Group, based in Vaud, Switzerland. Professor Vogel will work in close collaboration with the IMD Global Family Business Center, directed by Denise H. Kenyon Rouvinez, holder of the Wild Group Chair for Family Business.
The aim of the chair is to increase the social and financial impact of family philanthropy. The chair will facilitate the creation of best practices and will be the source of methodology to strengthen the analysis, decision-making processes, evaluation criteria, and governance in the area of family philanthropy. Another objective is to build upon and transmit common values to businesses and across family generations through philanthropy. This chair will reinforce IMD’s teaching and research and will contribute to generating knowledge in the wider field of family philanthropy.